NEW YORK, Aug. 29, 2018 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Ampio Pharmaceuticals, Inc. (“Ampio” or the “Company”) (NYSE: AMPE). Such investors are advised to contact Robert S. Willoughby at rswilloughby@ …
Go to Source